21-羟化酶缺陷所致经典型先天性肾上腺皮质增生症青少年及成年男性的挑战
本综述探讨21-羟化酶缺陷所致经典型先天性肾上腺皮质增生症青少年及成年男性在糖皮质激素治疗不足与过度之间平衡的临床挑战。青少年面临依从性和向独立过渡的困难,患者教育至关重要。定期监测、糖皮质激素剂量优化和预防性治疗被推荐以最大化生育潜力并保护长期骨骼健康,早期生活方式干预和药物治疗需用于应对心脏代谢后果。
要点
- 青少年依从性差可致最终身高降低、生殖健康受损、骨健康不良、肥胖和高血压。
- 即使激素控制良好,睾丸肾上腺剩余肿瘤(TARTs)仍可导致生育力低下/不育。
- 推荐定期监测、糖皮质激素剂量优化和预防性治疗以最大化生育潜力并保护骨骼健康。
核心结论
- 综述强调青少年和成年男性经典型先天性肾上腺皮质增生症患者需平衡糖皮质激素治疗,定期监测、剂量优化和预防性治疗被推荐以最大化生育潜力并保护长期骨骼健康,早期生活方式干预和药物治疗需用于应对心脏代谢后果。
研究设计与样本
- 本文为综述,检索范围原文未报告。
主要发现
- 激素控制不佳的男性常出现精子计数减少、睾丸小和良性睾丸肾上腺剩余肿瘤(TARTs)。
- 即使激素控制良好的男性,也可因TARTs出现生育力低下/不育。
- 性腺功能减退和长期糖皮质激素治疗等因素可使患者易出现骨健康不良(如骨密度低、骨质疏松/骨量减少和骨折风险增加)和代谢综合征(如肥胖、胰岛素抵抗、血脂异常和高血压)。
关键数值与推荐
- 推荐定期监测、糖皮质激素剂量优化和预防性治疗以最大化未来生育潜力并保护长期骨骼健康。
- 需要早期实施生活方式干预和药物治疗以应对心脏代谢后果。
临床怎么用
- 推荐定期监测、糖皮质激素剂量优化和预防性治疗以最大化未来生育潜力并保护长期骨骼健康。
- 需要早期实施生活方式干预和药物治疗以应对心脏代谢后果。
- 患者教育在青春期至关重要,尤其对控制不佳的青春期后男性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency results in severe cortisol and aldosterone deficiency, leading to persistent adrenal stimulation and excess production of ACTH and adrenal androgens. This review examines the clinical considerations and challenges of balancing under- and overtreatment with glucocorticoids in adolescent and adult male individuals with CAH. Adolescents face many unique challenges that can hinder adherence, hormonal control, and transition to independence. Thus, patient education is critical during adolescence, especially in poorly controlled postpubertal males who lack obvious symptoms and may not recognize the long-term consequences of nonadherence, such as reduced final height, reduced reproductive health, poor bone health, obesity, and hypertension. The risk of subfertility/infertility begins early, especially in males with poor hormonal control, who often have reduced sperm counts, small testes, and benign tumors called testicular adrenal rest tumors (TARTs). Even males with good hormonal control can experience subfertility/infertility due to TARTs. In addition, several factors such as hypogonadism and long-term glucocorticoid treatment can predispose males with CAH to poor bone health (eg, low bone mineral density, increased risk of osteoporosis/osteopenia and fractures) and metabolic syndrome (eg, obesity, insulin resistance, dyslipidemia, and hypertension). Regular monitoring is recommended, with glucocorticoid dose optimization and prophylactic treatment to maximize future fertility potential and protect long-term bone health. Early implementation of lifestyle interventions and medical treatment are needed to address cardiometabolic consequences.
引用
- Claahsen-van der Grinten HL, Adriaansen BPH, Falhammar H, et al. Challenges in Adolescent and Adult Males With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2025. PMID: 39836620. doi:10.1210/clinem/dgae718
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。